KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice

Search results for "lecanemab"

Home
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

“Lately, I keep forgetting appointments.” “They keep repeating what they just said.”When memory lapses in a parent become noticeable, families almost...
07/06/2026, 03:43 ET
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment injection drug ‘Lecanemab...
01/29/2026, 04:48 ET
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
06/11/2026, 07:43 ET
“65% of Dementia-Causing Protein Removed Without Drugs” Could Ultrasound Offer New Hope?

“65% of Dementia-Causing Protein Removed Without Drugs” Could Ultrasound Offer New Hope?

A South Korean research team has succeeded in removing a key substance implicated in Alzheimer’s disease using...
01/08/2026, 11:10 ET

"65% Reduction of Dementia-Causing Protein Without Drugs" Ultrasound, A New Hope?

A domestic research team has succeeded in removing the causative substances of Alzheimer's disease using ultrasound.
12/22/2025, 14:46 ET
1
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 41, Mapo-daero 4da-gil, Mapo-gu, Seoul, Henkel Tower (2nd Floor, Mapo Tower)
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All Rights Reserved.Powered by 팡고링고
Languages

ENGLISH

English (US)

ASIAN

日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية